Fierce Pharma Marketing Tees up Trends for 2021—and Big News, They're Not All COVID-19-Related
Por um escritor misterioso
Descrição
In this Fierce Pharma article, Leigh Householder at Syneos Health, shares: “It really is a pivot point. Pharma organizations [should] stand forward as the innovators they’ve always been. Creating change for people, creating longer lives and opportunities for better health.”
AZ, Merck, Takeda and more get their chance to shine in Q3
Trust in biopharma during COVID-19
DOJ says it's premature for Supreme Court to hear case challenging legality of ACA
TrendyMinds is a Finalist for Two 2021 Fierce Pharma…
If I'm Out of Insulin, I'm Going to Die”: United States' Lack of Regulation Fuels Crisis of Unaffordable Insulin
Fierce 50: Innovation honorees
Chart: Companies Fighting COVID-19 Immune to Market Weakness
2022 forecast: Marketing COVID vaccines and drugs, and how pharma, not brands, are taking center stage
2021 drug approvals: In a year dominated by COVID, biopharma managed to deliver 55 new drugs
de
por adulto (o preço varia de acordo com o tamanho do grupo)
